Key Takeaways Phase 2 retatrutide reduced mean systolic blood pressure by approximately 7-8 mmHg at top doses over 48 weeks Diastolic blood pressure dropped by approximately 2-4 mmHg Placebo arm BP changes were minimal, so the active-versus-placebo gap is real and meaningful The effect tracks with weight loss, suggesting most of the benefit is downstream of weight reduction rather than a direct vascular drug effect Patients on antihypertensive medications often need dose reductions as weight loss progresses to avoid excessive BP drops Direct answer Yes
This means it isnt always the best or safest choice for the health results youre hoping to achieve
Es gibt keinerlei Anhaltspunkte dafr, dass die Wirkung anderer Inhaltsstoffe, wie z
The point is to get you to your personal goal while keeping you safe and healthy.
Peng Q, Chen B, Wang H, Zhu Y, Wu J, Luo Y, Zuo G, Luo J, Zhou L, Shi Q, Weng Y, Huang A, He TC, Fan J
Injectable glutathione therapy should only be undertaken under the supervision of qualified healthcare providers who can assess individual appropriateness, monitor for adverse effects, and integrate glutathione therapy with comprehensive health management